Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 6.35% and Operating profit at -20.55% over the last 5 years
2
The company declared very negative results in Mar'25 after negative results in Dec'24
3
With ROE of 4.34%, it has a very expensive valuation with a 2.78 Price to Book Value
4
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.89%
0%
-3.89%
6 Months
-0.07%
0%
-0.07%
1 Year
1.39%
0%
1.39%
2 Years
8.98%
0%
8.98%
3 Years
3.6%
0%
3.6%
4 Years
58.78%
0%
58.78%
5 Years
26.42%
0%
26.42%
Shanghai No. 1 Pharmacy Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.35%
EBIT Growth (5y)
-20.55%
EBIT to Interest (avg)
5.25
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
1.61
Tax Ratio
24.25%
Dividend Payout Ratio
30.10%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.63%
ROE (avg)
10.06%
Valuation key factors
Factor
Value
P/E Ratio
64
Industry P/E
Price to Book Value
2.78
EV to EBIT
166.25
EV to EBITDA
29.88
EV to Capital Employed
3.54
EV to Sales
1.36
PEG Ratio
NA
Dividend Yield
1.60%
ROCE (Latest)
2.13%
ROE (Latest)
4.34%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
491.60
429.70
14.41%
Operating Profit (PBDIT) excl Other Income
13.20
5.90
123.73%
Interest
1.00
1.80
-44.44%
Exceptional Items
0.00
0.00
Consolidate Net Profit
9.50
93.70
-89.86%
Operating Profit Margin (Excl OI)
-9.80%
-24.70%
1.49%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 14.41% vs -1.92% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is -89.86% vs 478.40% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,909.30
1,811.20
5.42%
Operating Profit (PBDIT) excl Other Income
88.20
68.40
28.95%
Interest
6.80
8.20
-17.07%
Exceptional Items
-4.60
7.60
-160.53%
Consolidate Net Profit
163.60
89.30
83.20%
Operating Profit Margin (Excl OI)
8.40%
4.80%
0.36%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 5.42% vs -31.56% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 83.20% vs -37.81% in Dec 2023
About Shanghai No. 1 Pharmacy Co. Ltd. 
Shanghai No. 1 Pharmacy Co. Ltd.
Retailing
No Details Available.
Company Coordinates 
No Company Details Available






